|
Volumn 19, Issue 8, 2009, Pages 2315-2319
|
Synthesis and evaluation of arylalkoxy- and biarylalkoxy-phenylamide and phenylimidazoles as potent and selective sphingosine-1-phosphate receptor subtype-1 agonists
|
Author keywords
Arylalkoxy phenylamide; Arylalkoxy phenylimidazoles; Biarylalkoxy phenylamide; Biarylalkoxyphenylimidazoles; EDG1; FTY 720; Lymphopenia; S1P; S1P1 agonist; Sphingosine 1 phosphate
|
Indexed keywords
ANILIDE;
FINGOLIMOD;
IMIDAZOLE DERIVATIVE;
PHENYLIMIDAZOLE DERIVATIVE;
PPI 4667;
SPHINGOSINE 1 PHOSPHATE RECEPTOR;
SPHINGOSINE 1 PHOSPHATE RECEPTOR SUBTYPE 1 AGONIST;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CHEMICAL MODIFICATION;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG POTENCY;
DRUG SCREENING;
DRUG SELECTIVITY;
DRUG SYNTHESIS;
IN VITRO STUDY;
IN VIVO STUDY;
LYMPHOCYTOPENIA;
MOLECULAR BIOLOGY;
MOUSE;
NONHUMAN;
RAT;
AMIDES;
ANIMALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG EVALUATION, PRECLINICAL;
IMIDAZOLES;
MICE;
PROPYLENE GLYCOLS;
PROTEIN SUBUNITS;
RECEPTORS, LYSOSPHINGOLIPID;
SPHINGOSINE;
RATTUS;
|
EID: 63149102747
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2009.02.073 Document Type: Article |
Times cited : (10)
|
References (8)
|